Shen Qingshan, Yang Zhuan, Hu Chengzhi, Liu Yilin, Zhao Lei, Li Cuicui, Ma Yanli, Bian Hua
Henan Key Laboratory of Zhang Zhongjing Formulae and Herbs for Immunoregulation, Zhang Zhongjing College of Chinese Medicine, Nanyang Institute of Technology, Changjiang Road 80, Nanyang, 473004 Henan China.
School of Life Science and Agricultural Engineering, Nanyang Normal University, Wolong Road 1638, Nanyang, 473061 China.
Food Sci Biotechnol. 2024 Nov 27;34(9):1771-1788. doi: 10.1007/s10068-024-01745-3. eCollection 2025 May.
Obesity is recognized as a global epidemic that can result in changes in the human body and metabolism. Accumulating evidence indicates that gut microbiota (GM) can affect the development of obesity. The GM not only plays a crucial role in digesting and absorbing nutrients, but also in maintaining the overall health of the host. Dietary supplements such as non-starch polysaccharides are mainly fermented by the GM in the colon. Recent findings suggest that shaping the GM through the prebiotic function of non-starch polysaccharides may be a viable strategy against obesity. In this paper, the effects of non-starch polysaccharides on host health, together with their prebiotic function influencing the GM to control obesity via the gut-target organ axis, are reviewed. Potential perspectives of non-starch polysaccharides exhibiting anti-obesity effects via the gut-target organ axis are proposed for future research.
肥胖被认为是一种全球性流行病,可导致人体和新陈代谢发生变化。越来越多的证据表明,肠道微生物群(GM)会影响肥胖的发展。GM不仅在营养物质的消化和吸收中起关键作用,还在维持宿主的整体健康方面发挥作用。非淀粉多糖等膳食补充剂主要在结肠中由GM发酵。最近的研究结果表明,通过非淀粉多糖的益生元功能塑造GM可能是对抗肥胖的一种可行策略。本文综述了非淀粉多糖对宿主健康的影响,以及它们通过肠道-靶器官轴影响GM以控制肥胖的益生元功能。提出了非淀粉多糖通过肠道-靶器官轴发挥抗肥胖作用的潜在研究前景。